Azafaros procures about $28 mn Series A

Azafaros, a Dutch provider of treatments for rare metabolic disorders, has raised about $28 million in Series A financing.

Azafaros, a Dutch provider of treatments for rare metabolic disorders, has raised about $28 million in Series A financing. Forbion led the round with participation from BioMedPartners and BioGeneration Ventures.

Source: Press Release